scispace - formally typeset
V

Vamsi K. Mootha

Researcher at Broad Institute

Publications -  243
Citations -  90559

Vamsi K. Mootha is an academic researcher from Broad Institute. The author has contributed to research in topics: Mitochondrion & Mitochondrial DNA. The author has an hindex of 85, co-authored 227 publications receiving 73860 citations. Previous affiliations of Vamsi K. Mootha include Harvard University & Beth Israel Deaconess Medical Center.

Papers
More filters
Journal ArticleDOI

Mitochondrial Encephalomyopathy Due to a Novel Mutation in ACAD9

TL;DR: The data support the notion that ACad9 functions as a complex I assembly protein, and ACAD9 is a flavin adenine dinucleotide-containing flavoprotein, and treatment with riboflavin is advisable.
Patent

Methods and compositions for treating metabolic disorders

TL;DR: In this article, the present invention provides methods of treating of disorders characterized by defective mitochondrial activity, which can be used in the treatment metabolic diseases and neurodegenerative diseases and is also useful to increase oxidative phosphorylation or to decrease reactive oxygen species (ROS) production in a subject in need thereof.
Journal ArticleDOI

Crystal structure of MICU2 and comparison with MICU1 reveal insights into the uniporter gating mechanism

TL;DR: The structure of MICU2 is solved and it is proposed that in the MICU1–MICU2 oligomeric complex the C-terminal helices of both proteins form a central semiautonomous assembly which contributes to the gating mechanism of the uniporter.
Journal ArticleDOI

Airway stem cells sense hypoxia and differentiate into protective solitary neuroendocrine cells.

TL;DR: In this article, the authors identify stem cells that directly sense hypoxia and respond by differentiating into solitary NE cells that secrete a protective peptide that mitigates hypoxic injury.
Journal ArticleDOI

Atypical case of Wolfram syndrome revealed through targeted exome sequencing in a patient with suspected mitochondrial disease

TL;DR: Clinical application of next-generation sequencing technology can enhance the diagnosis of patients suspected to have rare genetic disorders and the finding of unexplained thiamine deficiency in a patient with Wolfram syndrome suggests a potential link between WFS1 biology andThiamine metabolism that has implications for the clinical management ofWolfram syndrome patients.